IVF IVF
Company Profile ↓Company Overview
IVF (IVF) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 38.5% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $6.84M (+4.3% YoY); net profit $-23.32M.
- Trailing 12 Months Year-on-year growth — revenue +4.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 38.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 38.51% |
| 1 Year: | 4.27% |
Stock Price Performance
| 1 Year: | -98.57% |
| 6 Months: | -81.47% |
| 3 Months: | -43.12% |
| 1 Month: | -19.78% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.06 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 38.5% over 5 years.
CONS
- Trading 98.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 258.57K | 246.07K | 336.07K | 684.52K | 208.47K | 218.87K | 162.60K | 146.13K | 235.32K | 348.02K | 315.90K | 974.89K | 1.58M | 1.84M | 1.43M | 1.64M | - | - | - |
| Gross Profit | 5.83K | 1.95K | -777 | 7.05K | 413 | 2.85K | 1.42K | 6.02K | -1.90K | 14.94K | 3.06K | 11.38K | 38.40K | 66.14K | 55.39K | 89.72K | 93.50K | 109.67K | 178.45K | 603.36K | 258.64K | 228.58K | 224.90K | 308.67K | 621.78K | 193.88K | 198.46K | 97.64K | 67.88K | 126.20K | 275.47K | - | - | - | - | - | - | - | - | - |
| Operating Income | -191.42K | -149.91K | -124.35K | -104.47K | -173.82K | -104.67K | -131.84K | -107.44K | -118.76K | -180.66K | -1.45M | -207.37K | -166.70K | -132.41K | -144.30K | -140.28K | -1.79M | -189.88K | -349.11K | -65.80K | -632.36K | -1.40M | -1.06M | -1.27M | -1.56M | -1.89M | -2.27M | -2.70M | -2.68M | -2.53M | -2.31M | -2.07M | -886.29K | -1.51M | -1.85M | -1.30M | -1.20M | -2.99M | -1.64M | -1.59M |
| Net Income | -302.68K | -104.89K | -213.97K | -117.32K | -186.77K | -117.72K | -144.66K | -4.45M | -123.19K | -181.31K | -1.46M | -210.82K | -214.87K | -136.97K | -148.85K | -144.72K | -1.87M | -294.86K | -458.57K | -241.55K | -710.33K | -1.44M | -1.32M | -1.77M | -2.45M | -1.82M | -2.24M | -2.77M | -2.80M | -2.55M | -2.55M | -2.24M | -1.25M | -1.60M | -2.25M | -1.63M | -17.40M | -3.62M | -3.40M | -5.54M |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -0.03 | -0.15 | -0.29 | -0.27 | -0.36 | -0.25 | -0.17 | -0.24 | -0.23 | -4.62 | -4.19 | -4.10 | -3.06 | -0.70 | -7.55 | -22.39 | -15.11 | -3,473.93 | -364.23 | -39.40 | -3.38 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 30.05K | 34.89K | 112.55K | 66.27K | 31.02K | 55.39K | 104.18K | 190.76K | 175.27K | 73.52K | 83.85K | 2.67K | 4.88K | - | - | 265.66K | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 71.50K | 56.38K | 27.06K | 16.59K | 11.69K | 50.90K | 282.14K | 494.38K | 1.48M | 1.04M | 4.16M | 822.20K | 3.02M | 6.56M | 6.84M |
| Gross Profit | 53.59K | 35.50K | 16.48K | 8.91K | 3.88K | 35.81K | 230.19K | 404.01K | 1.34M | 948.53K | 4.02M | 490.67K | - | - | - |
| Operating Income | -703.13K | -552.30K | -605.23K | -1.68M | -595.07K | -2.11M | -640.42K | -2.63M | -1.79M | -5.51M | -5.22M | -10.63M | -6.77M | -6.63M | -7.24M |
| Net Income | -797.47K | -666.45K | -760.68K | -1.73M | -4.96M | -2.12M | -702.16K | -3.08M | -2.17M | -8.35M | -6.65M | -10.89M | -8.03M | -9.26M | -23.32M |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 | -0.02 | 0.00 | -0.02 | -0.45 | -1.52 | -0.63 | -17.97 | -67.37 | -3,782.65 | -214.64 |
| R&D Expense | - | - | - | - | - | - | - | - | 0 | 398.43K | 216.43K | 544.04K | 165.94K | 4.88K | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 127.88K | 128.12K | 150.27K | 140.29K | 125.27K | 116.61K | 115.16K | 114.98K | 122.54K | 114.83K | 105.78K | 101.57K | 108.05K | 113.74K | 164.81K | 199.18K | 579.79K | 286.23K | 266.41K | 777.35K | 1.80M | 10.95M | 10.47M | 4.10M | 18.51M | 46.08M | - | - | - | 20.22M |
| Total Equity | -2.48M | -2.93M | -3.05M | -3.13M | -3.35M | -3.37M | -3.60M | -3.65M | -3.84M | -3.81M | -3.93M | -4.12M | -4.24M | -4.36M | -4.48M | -4.04M | -4.10M | -3.76M | -4.62M | -4.99M | -2.72M | -3.71M | 5.74M | 7.31M | -977.61K | 892.83K | 12.58M | -27.04M | -6.99M | 5.82M | 7.22M |
| Cash & Equivalents | 12.53K | 403 | 887 | 31.46K | 27.69K | 7.19K | 687 | 2.27K | 7.50K | 18.03K | 7.26K | 8.63K | 6.27K | 18.63K | 24.47K | 79.62K | 114.56K | 492.00K | 152.40K | 25.76K | 212.24K | 1.24M | 10.10M | 5.68M | - | - | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.13M | - | - | - | 744.73K |
| Total Liabilities | - | 3.05M | 3.18M | 3.28M | 3.49M | 3.50M | 3.72M | 3.77M | 3.96M | 3.94M | 4.05M | 4.22M | 4.34M | 4.47M | 4.59M | 4.21M | 4.30M | 4.34M | 4.90M | 5.26M | 3.50M | 5.51M | 5.20M | 3.16M | 5.08M | 17.61M | 26.04M | - | 16.19M | 13.01M | 13.00M |
| Current Liabilities | - | 3.05M | 3.18M | 3.28M | 3.49M | 3.50M | 3.72M | 3.77M | 3.96M | 3.94M | 4.05M | 4.22M | 4.34M | 4.47M | 4.59M | 4.21M | 4.30M | 4.34M | 4.77M | 5.13M | 3.50M | 1.50M | 2.29M | 1.25M | 3.41M | 8.00M | 17.87M | - | 12.14M | 9.13M | 10.33M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -117.78K | -43.21K | -59.92K | -19.40K | -151.62K | -323.90K | -181.27K | -652.97K | 1.37M | -4.78M | -6.03M | -6.60M | -4.76M | -2.97M | -7.01M |
| Investing Cash Flow | - | - | - | - | 0 | -15.70K | 0 | -19.40K | -114.71K | -187.25K | -2.15M | -81.22K | -2.49M | 363.89K | -2.75M |
| Financing Cash Flow | 105.66K | 50.00K | 70.75K | 20.00K | 625.00K | 0 | 54.62K | 858.86K | -229.47K | 13.82M | 3.77M | 1.09M | 7.39M | 3.12M | 11.10M |
| Capital Expenditure | - | - | - | - | -0 | -15.70K | -0 | -19.40K | -64.84K | -49.26K | -415.71K | -10.79K | -444.72K | -183.70K | -43.41K |
| Free Cash Flow | - | - | - | - | -151.62K | -339.60K | -181.27K | -672.37K | 1.31M | -4.82M | -6.45M | -6.61M | -5.20M | -3.16M | -7.06M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 74.9% | 63.0% | 60.9% | 53.7% | 33.2% | 70.3% | 81.6% | 81.7% | 90.6% | 91.4% | 96.5% | 59.7% | - | - | - |
| Operating Margin % | -983.4% | -979.7% | -2,236.4% | -10,131.3% | -5,090.9% | -4,146.1% | -227.0% | -532.8% | -120.8% | -531.7% | -125.4% | -1,292.5% | -224.0% | -101.0% | -105.8% |
| Net Margin % | -1,115.3% | -1,182.1% | -2,810.8% | -10,444.1% | -42,426.6% | -4,173.3% | -248.9% | -622.2% | -146.4% | -804.7% | -160.0% | -1,324.8% | -266.0% | -141.1% | -340.9% |
| ROE % | 27.3% | 19.8% | 19.9% | 39.7% | 132.0% | 46.0% | 14.1% | 112.9% | 58.4% | -145.3% | -91.0% | 1,114.2% | -899.9% | -73.6% | -322.8% |
| ROCE % | 24.0% | 16.4% | 15.9% | 38.6% | 15.8% | 47.0% | 13.2% | 96.7% | -607.4% | -63.7% | -56.6% | -1,530.6% | -64.4% | -23.5% | -73.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IVF
INVO Fertility Stock Short Interest Rises to 42.71% | IVF Stock News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOLWN0N1RkTHB2XzVvSWZ0Y1dwV2tHRzd5OXh2YjF6djhZemRhODlDSVIxWkFHRDlWMmhoM1VpSENWay1wdEY1bDRPTVRCT18xZUVQREcxb2FvMEJCeXcwNmVXQjFMYlpXSUtHT3lra3gxNkRhbTlhWlNRNXZHVGFnSkVVY0NXTFdpUkE1N0…
INVO Fertility, Inc. Revenue Breakdown – NASDAQ:IVF - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBUWVAxamh1V3VzcFpGMVJaZF83Y05ZWkJLQ0RrY0l4M2puNHhYWU1IbEpFOUFGVzI3dWhMdjNNX0VPS0FJUFRVb29jWVZwNHdiNDhkYU1qSWNzUHhXWGFGOVFCaDJkUU40YUFmaTFleU1qVy1yQVE?oc=5" target="_blank">INVO Fer…
SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPZHlDVUlfRUlJQTUtWnlkNk8xR3FyVjlqQmx6SGVIT0pKR3M5cW8weU1jaFBOQVI4MVNDaXRjX2ZETl9XNTU3UmVQTjR3dV82VnBCcndQMXVmaF9IY1oxOFd4allJQ213Vko4azU1bTB6V3o3Q2hWZUp4QnlmRlEwVG5FOFBJUEJvTjlIYn…
Traders are paying attention to the gapping stocks in Friday's session. - ChartMill
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQclRPVmN2RUJpSUNFaXpwdkJtZXlBaXgwX29PV1ZYVUp6MWg4bVRwS0hOMFp1dmw2YXYyTnpDb3dwVmZvS29fVkZzUFhVaWVFSWRsaXItSnNoM1ZvYkpDazFNdlZoSHJGd01rc2tuVUE1VGpmdTlGOVlaTU1wdlNCcWF4VjAtanBKaEpzMW…
INVO Fertility (IVF) lines up $15M–$50M stock sale program - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTjcyazVaRkFoTWZobVlSX3BwdmRVSkVIYkczeGFGbVNfNllWOE9xVWVCdmRUeG5ySkNSSFQ1OXg0XzVFdHhBTTF6LXhOOG5raXJyTUczNmJhSGIyeVZyVFpYbDl4YUNvcDRsUWNxTWFidlBNa2xQR0Z5djBXU2ZMY2lxZ25PZVhIN0U0RE…
Read This Before Considering IVF Hartmann Holding AG (VTX:VBSN) For Its Upcoming CHF03.80 Dividend - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNUHNpdnBSc2FMRG5oNDhYYTJQaG1JMDhTcDZ0V2VJZDVFOE1MZkFjVVhzTUFwRWN3VnpZUi1lYklPcFF3MjVncWM1QVlPOUY3MmFFbDlVbE5ZVUJQVnY0VnlsTllUTHRBMjdGSWRZT2htR1FNZFpDZ0JMT0w0aVBpTDlSZzV1NG55bXpqZD…
IVF — Frequently Asked Questions
What is the current share price of IVF?
As of 2026-08-05 17:25 PDT, IVF trades at $1.08 on NASDAQ/NYSE. Its 52-week range is $0.91 to $75.20.
What is the P/E ratio of IVF?
IVF trades at a trailing price-to-earnings (P/E) ratio of -0.01.
Is IVF a good stock to buy?
This page provides a data-driven analysis of IVF, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.